Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
CAR T-cell therapy is a cancer treatment that uses a patient’s own immune system cells, called T cells, after these cells have been modified to better recognize and kill the patient’s cancer. The T cells are engineered in the laboratory and then expanded to large numbers and infused back into the patient. This type of treatment transfers an immune system into the patient that is capable of immediately killing the cancer. CAR stands for chimeric antigen receptor, which represents the genetically engineered portion of the T cell. The CAR part of the T cell contains proteins that allow the T cells to recognize the specific cancer cells as well as become highly activated to kill the cancer cells.
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Chimeric Antigen Receptor (CAR) T-Cell Therapy market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Chimeric Antigen Receptor (CAR) T-Cell Therapy market are covered in Chapter 9:
Juno Therapeutics Inc. (A Celgene Company)
Mustang Bio Inc.
Puretech Health
Celyad SA
Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.)
Amgen
Shire Pharmaceuticals Inc.
Celgene Corp.
F. Hoffman La Roche AG
Novartis AG
Protheragen Inc.
Cellectis
iCell Gene Therapeutics
Medimmune Llc/Astrazeneca
Bellicum Phamaceuticals
Editas Medicine Inc.
Gilead Sciences
Transgene SA
Avacta Life Sciences Ltd.
Takeda Pharmaceuticals
Bluebird Bio
Formula Pharmaceuticals Inc.
Servier Laboratories
Eureka Therapeutics Inc.
Noile-Immune Biotech
In Chapter 5 and Chapter 7.3, based on types, the Chimeric Antigen Receptor (CAR) T-Cell Therapy market from 2017 to 2027 is primarily split into:
Acute Lymphoblastic Leukemia (ALL)
Advanced Lymphomas
Others
In Chapter 6 and Chapter 7.4, based on applications, the Chimeric Antigen Receptor (CAR) T-Cell Therapy market from 2017 to 2027 covers:
Children
Adult
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Chimeric Antigen Receptor (CAR) T-Cell Therapy market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Chimeric Antigen Receptor (CAR) T-Cell Therapy market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Chimeric Antigen Receptor (CAR) T-Cell Therapy market are covered in Chapter 9:
Juno Therapeutics Inc. (A Celgene Company)
Mustang Bio Inc.
Puretech Health
Celyad SA
Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.)
Amgen
Shire Pharmaceuticals Inc.
Celgene Corp.
F. Hoffman La Roche AG
Novartis AG
Protheragen Inc.
Cellectis
iCell Gene Therapeutics
Medimmune Llc/Astrazeneca
Bellicum Phamaceuticals
Editas Medicine Inc.
Gilead Sciences
Transgene SA
Avacta Life Sciences Ltd.
Takeda Pharmaceuticals
Bluebird Bio
Formula Pharmaceuticals Inc.
Servier Laboratories
Eureka Therapeutics Inc.
Noile-Immune Biotech
In Chapter 5 and Chapter 7.3, based on types, the Chimeric Antigen Receptor (CAR) T-Cell Therapy market from 2017 to 2027 is primarily split into:
Acute Lymphoblastic Leukemia (ALL)
Advanced Lymphomas
Others
In Chapter 6 and Chapter 7.4, based on applications, the Chimeric Antigen Receptor (CAR) T-Cell Therapy market from 2017 to 2027 covers:
Children
Adult
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Chimeric Antigen Receptor (CAR) T-Cell Therapy market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY MARKET OVERVIEW
1.1 Product Overview and Scope of Chimeric Antigen Receptor (CAR) T-Cell Therapy Market
1.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Segment by Type
1.2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Segment by Application
1.3.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, Region Wise (2017-2027)
1.4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2027)
1.4.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2027)
1.4.4 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2027)
1.4.5 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2027)
1.4.6 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2027)
1.4.8 Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2027)
1.5 Global Market Size of Chimeric Antigen Receptor (CAR) T-Cell Therapy (2017-2027)
1.5.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Chimeric Antigen Receptor (CAR) T-Cell Therapy Market
2 INDUSTRY OUTLOOK
2.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Drivers Analysis
2.4 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Development
3 GLOBAL CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY MARKET LANDSCAPE BY PLAYER
3.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Share by Player (2017-2022)
3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Market Share by Player (2017-2022)
3.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Average Price by Player (2017-2022)
3.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Gross Margin by Player (2017-2022)
3.5 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Competitive Situation and Trends
3.5.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Concentration Rate
3.5.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
4.5 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
4.6 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
4.7 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
4.8 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
4.9 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
4.10 Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
4.11 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
5 GLOBAL CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Market Share by Type (2017-2022)
5.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Market Share by Type (2017-2022)
5.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Price by Type (2017-2022)
5.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue and Growth Rate of Acute Lymphoblastic Leukemia (ALL) (2017-2022)
5.4.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue and Growth Rate of Advanced Lymphomas (2017-2022)
5.4.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue and Growth Rate of Others (2017-2022)
6 GLOBAL CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY MARKET ANALYSIS BY APPLICATION
6.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Market Share by Application (2017-2022)
6.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Growth Rate of Children (2017-2022)
6.3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Growth Rate of Adult (2017-2022)
7 GLOBAL CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY MARKET FORECAST (2022-2027)
7.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Price and Trend Forecast (2022-2027)
7.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate of Acute Lymphoblastic Leukemia (ALL) (2022-2027)
7.3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate of Advanced Lymphomas (2022-2027)
7.3.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate of Others (2022-2027)
7.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Forecast by Application (2022-2027)
7.4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Value and Growth Rate of Children(2022-2027)
7.4.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Value and Growth Rate of Adult(2022-2027)
7.5 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Under COVID-19
8 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Chimeric Antigen Receptor (CAR) T-Cell Therapy Analysis
8.6 Major Downstream Buyers of Chimeric Antigen Receptor (CAR) T-Cell Therapy Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry
9 PLAYERS PROFILES
9.1 Juno Therapeutics Inc. (A Celgene Company)
9.1.1 Juno Therapeutics Inc. (A Celgene Company) Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.1.3 Juno Therapeutics Inc. (A Celgene Company) Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Mustang Bio Inc.
9.2.1 Mustang Bio Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.2.3 Mustang Bio Inc. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Puretech Health
9.3.1 Puretech Health Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.3.3 Puretech Health Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Celyad SA
9.4.1 Celyad SA Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.4.3 Celyad SA Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.)
9.5.1 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.5.3 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Amgen
9.6.1 Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.6.3 Amgen Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Shire Pharmaceuticals Inc.
9.7.1 Shire Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.7.3 Shire Pharmaceuticals Inc. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Celgene Corp.
9.8.1 Celgene Corp. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.8.3 Celgene Corp. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 F. Hoffman La Roche AG
9.9.1 F. Hoffman La Roche AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.9.3 F. Hoffman La Roche AG Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Novartis AG
9.10.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.10.3 Novartis AG Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Protheragen Inc.
9.11.1 Protheragen Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.11.3 Protheragen Inc. Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Cellectis
9.12.1 Cellectis Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.12.3 Cellectis Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 iCell Gene Therapeutics
9.13.1 iCell Gene Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.13.3 iCell Gene Therapeutics Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Medimmune Llc/Astrazeneca
9.14.1 Medimmune Llc/Astrazeneca Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.14.3 Medimmune Llc/Astrazeneca Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Bellicum Phamaceuticals
9.15.1 Bellicum Phamaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.15.3 Bellicum Phamaceuticals Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Editas Medicine Inc.
9.16.1 Editas Medicine Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.16.3 Editas Medicine Inc. Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Gilead Sciences
9.17.1 Gilead Sciences Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.17.3 Gilead Sciences Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
9.18 Transgene SA
9.18.1 Transgene SA Basic Information, Manufacturing Base, Sales Region and Competitors
9.18.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.18.3 Transgene SA Market Performance (2017-2022)
9.18.4 Recent Development
9.18.5 SWOT Analysis
9.19 Avacta Life Sciences Ltd.
9.19.1 Avacta Life Sciences Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.19.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.19.3 Avacta Life Sciences Ltd. Market Performance (2017-2022)
9.19.4 Recent Development
9.19.5 SWOT Analysis
9.20 Takeda Pharmaceuticals
9.20.1 Takeda Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.20.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.20.3 Takeda Pharmaceuticals Market Performance (2017-2022)
9.20.4 Recent Development
9.20.5 SWOT Analysis
9.21 Bluebird Bio
9.21.1 Bluebird Bio Basic Information, Manufacturing Base, Sales Region and Competitors
9.21.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.21.3 Bluebird Bio Market Performance (2017-2022)
9.21.4 Recent Development
9.21.5 SWOT Analysis
9.22 Formula Pharmaceuticals Inc.
9.22.1 Formula Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.22.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.22.3 Formula Pharmaceuticals Inc. Market Performance (2017-2022)
9.22.4 Recent Development
9.22.5 SWOT Analysis
9.23 Servier Laboratories
9.23.1 Servier Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
9.23.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.23.3 Servier Laboratories Market Performance (2017-2022)
9.23.4 Recent Development
9.23.5 SWOT Analysis
9.24 Eureka Therapeutics Inc.
9.24.1 Eureka Therapeutics Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.24.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.24.3 Eureka Therapeutics Inc. Market Performance (2017-2022)
9.24.4 Recent Development
9.24.5 SWOT Analysis
9.25 Noile-Immune Biotech
9.25.1 Noile-Immune Biotech Basic Information, Manufacturing Base, Sales Region and Competitors
9.25.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.25.3 Noile-Immune Biotech Market Performance (2017-2022)
9.25.4 Recent Development
9.25.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Chimeric Antigen Receptor (CAR) T-Cell Therapy Market
1.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Segment by Type
1.2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Segment by Application
1.3.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market, Region Wise (2017-2027)
1.4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2027)
1.4.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2027)
1.4.4 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2027)
1.4.5 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2027)
1.4.6 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2027)
1.4.8 Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Status and Prospect (2017-2027)
1.5 Global Market Size of Chimeric Antigen Receptor (CAR) T-Cell Therapy (2017-2027)
1.5.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Chimeric Antigen Receptor (CAR) T-Cell Therapy Market
2 INDUSTRY OUTLOOK
2.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Drivers Analysis
2.4 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Development
3 GLOBAL CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY MARKET LANDSCAPE BY PLAYER
3.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Share by Player (2017-2022)
3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Market Share by Player (2017-2022)
3.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Average Price by Player (2017-2022)
3.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Gross Margin by Player (2017-2022)
3.5 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Competitive Situation and Trends
3.5.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Concentration Rate
3.5.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
4.5 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
4.6 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
4.7 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
4.8 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
4.9 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
4.10 Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
4.11 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Under COVID-19
5 GLOBAL CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Market Share by Type (2017-2022)
5.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Market Share by Type (2017-2022)
5.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Price by Type (2017-2022)
5.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue and Growth Rate of Acute Lymphoblastic Leukemia (ALL) (2017-2022)
5.4.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue and Growth Rate of Advanced Lymphomas (2017-2022)
5.4.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue and Growth Rate of Others (2017-2022)
6 GLOBAL CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY MARKET ANALYSIS BY APPLICATION
6.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Market Share by Application (2017-2022)
6.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Growth Rate of Children (2017-2022)
6.3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Growth Rate of Adult (2017-2022)
7 GLOBAL CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY MARKET FORECAST (2022-2027)
7.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Price and Trend Forecast (2022-2027)
7.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate of Acute Lymphoblastic Leukemia (ALL) (2022-2027)
7.3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate of Advanced Lymphomas (2022-2027)
7.3.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate of Others (2022-2027)
7.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Forecast by Application (2022-2027)
7.4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Value and Growth Rate of Children(2022-2027)
7.4.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Value and Growth Rate of Adult(2022-2027)
7.5 Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Under COVID-19
8 CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Chimeric Antigen Receptor (CAR) T-Cell Therapy Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Chimeric Antigen Receptor (CAR) T-Cell Therapy Analysis
8.6 Major Downstream Buyers of Chimeric Antigen Receptor (CAR) T-Cell Therapy Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry
9 PLAYERS PROFILES
9.1 Juno Therapeutics Inc. (A Celgene Company)
9.1.1 Juno Therapeutics Inc. (A Celgene Company) Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.1.3 Juno Therapeutics Inc. (A Celgene Company) Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Mustang Bio Inc.
9.2.1 Mustang Bio Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.2.3 Mustang Bio Inc. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Puretech Health
9.3.1 Puretech Health Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.3.3 Puretech Health Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Celyad SA
9.4.1 Celyad SA Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.4.3 Celyad SA Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.)
9.5.1 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.5.3 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Amgen
9.6.1 Amgen Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.6.3 Amgen Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Shire Pharmaceuticals Inc.
9.7.1 Shire Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.7.3 Shire Pharmaceuticals Inc. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Celgene Corp.
9.8.1 Celgene Corp. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.8.3 Celgene Corp. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 F. Hoffman La Roche AG
9.9.1 F. Hoffman La Roche AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.9.3 F. Hoffman La Roche AG Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Novartis AG
9.10.1 Novartis AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.10.3 Novartis AG Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Protheragen Inc.
9.11.1 Protheragen Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.11.3 Protheragen Inc. Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Cellectis
9.12.1 Cellectis Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.12.3 Cellectis Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 iCell Gene Therapeutics
9.13.1 iCell Gene Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.13.3 iCell Gene Therapeutics Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Medimmune Llc/Astrazeneca
9.14.1 Medimmune Llc/Astrazeneca Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.14.3 Medimmune Llc/Astrazeneca Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Bellicum Phamaceuticals
9.15.1 Bellicum Phamaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.15.3 Bellicum Phamaceuticals Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Editas Medicine Inc.
9.16.1 Editas Medicine Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.16.3 Editas Medicine Inc. Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Gilead Sciences
9.17.1 Gilead Sciences Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.17.3 Gilead Sciences Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
9.18 Transgene SA
9.18.1 Transgene SA Basic Information, Manufacturing Base, Sales Region and Competitors
9.18.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.18.3 Transgene SA Market Performance (2017-2022)
9.18.4 Recent Development
9.18.5 SWOT Analysis
9.19 Avacta Life Sciences Ltd.
9.19.1 Avacta Life Sciences Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.19.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.19.3 Avacta Life Sciences Ltd. Market Performance (2017-2022)
9.19.4 Recent Development
9.19.5 SWOT Analysis
9.20 Takeda Pharmaceuticals
9.20.1 Takeda Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.20.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.20.3 Takeda Pharmaceuticals Market Performance (2017-2022)
9.20.4 Recent Development
9.20.5 SWOT Analysis
9.21 Bluebird Bio
9.21.1 Bluebird Bio Basic Information, Manufacturing Base, Sales Region and Competitors
9.21.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.21.3 Bluebird Bio Market Performance (2017-2022)
9.21.4 Recent Development
9.21.5 SWOT Analysis
9.22 Formula Pharmaceuticals Inc.
9.22.1 Formula Pharmaceuticals Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.22.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.22.3 Formula Pharmaceuticals Inc. Market Performance (2017-2022)
9.22.4 Recent Development
9.22.5 SWOT Analysis
9.23 Servier Laboratories
9.23.1 Servier Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
9.23.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.23.3 Servier Laboratories Market Performance (2017-2022)
9.23.4 Recent Development
9.23.5 SWOT Analysis
9.24 Eureka Therapeutics Inc.
9.24.1 Eureka Therapeutics Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.24.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.24.3 Eureka Therapeutics Inc. Market Performance (2017-2022)
9.24.4 Recent Development
9.24.5 SWOT Analysis
9.25 Noile-Immune Biotech
9.25.1 Noile-Immune Biotech Basic Information, Manufacturing Base, Sales Region and Competitors
9.25.2 Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Profiles, Application and Specification
9.25.3 Noile-Immune Biotech Market Performance (2017-2022)
9.25.4 Recent Development
9.25.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Picture
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume and CAGR (%) Comparison by Type
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Development
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume by Player (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Share by Player (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Share by Player in 2021
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) by Player (2017-2022)
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share by Player (2017-2022)
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Price by Player (2017-2022)
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Region Wise (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Market Share, Region Wise in 2021
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD), Region Wise (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, Region Wise (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, Region Wise (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, Region Wise in 2021
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume by Type (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Market Share by Type (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Market Share by Type in 2021
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) by Type (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share by Type (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share by Type in 2021
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Price by Type (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Growth Rate of Acute Lymphoblastic Leukemia (ALL) (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) and Growth Rate of Acute Lymphoblastic Leukemia (ALL) (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Growth Rate of Advanced Lymphomas (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) and Growth Rate of Advanced Lymphomas (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption by Application (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Market Share by Application (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Revenue Market Share by Application (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Growth Rate of Children (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Growth Rate of Adult (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Price and Trend Forecast (2022-2027)
Figure USA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume Forecast, by Type
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Market Share Forecast, by Type
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) Forecast, by Type
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share Forecast, by Type
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Price Forecast, by Type
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) and Growth Rate of Acute Lymphoblastic Leukemia (ALL) (2022-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) and Growth Rate of Acute Lymphoblastic Leukemia (ALL) (2022-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) and Growth Rate of Advanced Lymphomas (2022-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) and Growth Rate of Advanced Lymphomas (2022-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Consumption Forecast, by Application
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Market Share Forecast, by Application
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) Forecast, by Application
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share Forecast, by Application
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Value (Million USD) and Growth Rate of Children (2022-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Value (Million USD) and Growth Rate of Adult (2022-2027)
Figure Chimeric Antigen Receptor (CAR) T-Cell Therapy Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Juno Therapeutics Inc. (A Celgene Company) Profile
Table Juno Therapeutics Inc. (A Celgene Company) Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Juno Therapeutics Inc. (A Celgene Company) Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Growth Rate
Figure Juno Therapeutics Inc. (A Celgene Company) Revenue (Million USD) Market Share 2017-2022
Table Mustang Bio Inc. Profile
Table Mustang Bio Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mustang Bio Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Growth Rate
Figure Mustang Bio Inc. Revenue (Million USD) Market Share 2017-2022
Table Puretech Health Profile
Table Puretech Health Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Puretech Health Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Growth Rate
Figure Puretech Health Revenue (Million USD) Market Share 2017-2022
Table Celyad SA Profile
Table Celyad SA Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celyad SA Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Growth Rate
Figure Celyad SA Revenue (Million USD) Market Share 2017-2022
Table Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Profile
Table Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Growth Rate
Figure Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Revenue (Million USD) Market Share 2017-2022
Table Amgen Profile
Table Amgen Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Growth Rate
Figure Amgen Revenue (Million USD) Market Share 2017-2022
Table Shire Pharmaceuticals Inc. Profile
Table Shire Pharmaceuticals Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Shire Pharmaceuticals Inc. Chimeric Antigen Receptor (CAR) T-Ce
Figure Chimeric Antigen Receptor (CAR) T-Cell Therapy Product Picture
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume and CAGR (%) Comparison by Type
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Chimeric Antigen Receptor (CAR) T-Cell Therapy Industry Development
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume by Player (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Share by Player (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Share by Player in 2021
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) by Player (2017-2022)
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share by Player (2017-2022)
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Price by Player (2017-2022)
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Region Wise (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Market Share, Region Wise in 2021
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD), Region Wise (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, Region Wise (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, Region Wise (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share, Region Wise in 2021
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume by Type (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Market Share by Type (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Market Share by Type in 2021
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) by Type (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share by Type (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share by Type in 2021
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Price by Type (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Growth Rate of Acute Lymphoblastic Leukemia (ALL) (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) and Growth Rate of Acute Lymphoblastic Leukemia (ALL) (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Growth Rate of Advanced Lymphomas (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) and Growth Rate of Advanced Lymphomas (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption by Application (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Market Share by Application (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Revenue Market Share by Application (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Growth Rate of Children (2017-2022)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption and Growth Rate of Adult (2017-2022)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Price and Trend Forecast (2022-2027)
Figure USA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales Volume Forecast, by Type
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume Market Share Forecast, by Type
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) Forecast, by Type
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share Forecast, by Type
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Price Forecast, by Type
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) and Growth Rate of Acute Lymphoblastic Leukemia (ALL) (2022-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) and Growth Rate of Acute Lymphoblastic Leukemia (ALL) (2022-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) and Growth Rate of Advanced Lymphomas (2022-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) and Growth Rate of Advanced Lymphomas (2022-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Consumption Forecast, by Application
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Market Share Forecast, by Application
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue (Million USD) Forecast, by Application
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share Forecast, by Application
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Value (Million USD) and Growth Rate of Children (2022-2027)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Consumption Value (Million USD) and Growth Rate of Adult (2022-2027)
Figure Chimeric Antigen Receptor (CAR) T-Cell Therapy Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Juno Therapeutics Inc. (A Celgene Company) Profile
Table Juno Therapeutics Inc. (A Celgene Company) Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Juno Therapeutics Inc. (A Celgene Company) Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Growth Rate
Figure Juno Therapeutics Inc. (A Celgene Company) Revenue (Million USD) Market Share 2017-2022
Table Mustang Bio Inc. Profile
Table Mustang Bio Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mustang Bio Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Growth Rate
Figure Mustang Bio Inc. Revenue (Million USD) Market Share 2017-2022
Table Puretech Health Profile
Table Puretech Health Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Puretech Health Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Growth Rate
Figure Puretech Health Revenue (Million USD) Market Share 2017-2022
Table Celyad SA Profile
Table Celyad SA Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celyad SA Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Growth Rate
Figure Celyad SA Revenue (Million USD) Market Share 2017-2022
Table Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Profile
Table Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Growth Rate
Figure Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Revenue (Million USD) Market Share 2017-2022
Table Amgen Profile
Table Amgen Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amgen Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume and Growth Rate
Figure Amgen Revenue (Million USD) Market Share 2017-2022
Table Shire Pharmaceuticals Inc. Profile
Table Shire Pharmaceuticals Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Shire Pharmaceuticals Inc. Chimeric Antigen Receptor (CAR) T-Ce
